AMD - AGE-RELATED MACULAR DEGENERATION
Clinical trials for AMD - AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AMD - AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AMD - AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to fight leading cause of vision loss
Disease control Recruiting nowThis is the first human study testing a new oral medication called ABF-101 for age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The study will check if the drug is safe and how it moves through the body in 68 healthy volunteers and people wi…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Gas bubble eye treatment: does bleed type matter for recovery?
Disease control Recruiting nowThis study looks at whether the type of abnormal blood vessel growth affects recovery when treating eye bleeds with a gas bubble procedure. Researchers will follow 60 patients with age-related macular degeneration who receive this treatment within 36 hours of their bleed. They'll…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Sponsor: Marco Mazzola • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC